Cargando…
Recurrent aseptic meningitis with PIGT mutations: a novel pathogenesis of recurrent meningitis successfully treated by eculizumab
We report the case of a patient with PIGT mutations who experienced recurrent aseptic meningitis 121 times over 16 years before developing paroxysmal nocturnal haemoglobinuria (PNH). Each episode was preceded by urticaria and arthralgia. After developing PNH, haemolysis occurred prior to meningitis....
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169622/ https://www.ncbi.nlm.nih.gov/pubmed/30262533 http://dx.doi.org/10.1136/bcr-2018-225910 |
_version_ | 1783360543586779136 |
---|---|
author | Kawamoto, Michi Murakami, Yoshiko Kinoshita, Taroh Kohara, Nobuo |
author_facet | Kawamoto, Michi Murakami, Yoshiko Kinoshita, Taroh Kohara, Nobuo |
author_sort | Kawamoto, Michi |
collection | PubMed |
description | We report the case of a patient with PIGT mutations who experienced recurrent aseptic meningitis 121 times over 16 years before developing paroxysmal nocturnal haemoglobinuria (PNH). Each episode was preceded by urticaria and arthralgia. After developing PNH, haemolysis occurred prior to meningitis. Flow cytometry revealed deficiency of the glycophosphatidylinositol (GPI)-anchored complement regulatory proteins, CD59 and CD55, and he was diagnosed with PNH. All the symptoms disappeared on administering eculizumab, an anti-C5 antibody. We did not detect mutation in PIGA, which is regarded as the cause of PNH. However, we detected a germ-line mutation and a somatic microdeletion in chromosome 20q including PIGT; PIGT is essential for transferring GPI anchor to the precursors of CD59 and CD55, which play important roles in complement regulation. Loss of these proteins leads to complement overactivation, causing inflammatory symptoms, including recurrent meningitis. PIGT mutations should be considered a novel pathogenesis of recurrent meningitis of unknown aetiology. |
format | Online Article Text |
id | pubmed-6169622 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-61696222018-10-05 Recurrent aseptic meningitis with PIGT mutations: a novel pathogenesis of recurrent meningitis successfully treated by eculizumab Kawamoto, Michi Murakami, Yoshiko Kinoshita, Taroh Kohara, Nobuo BMJ Case Rep Findings That Shed New Light on the Possible Pathogenesis of a Disease or an Adverse Effect We report the case of a patient with PIGT mutations who experienced recurrent aseptic meningitis 121 times over 16 years before developing paroxysmal nocturnal haemoglobinuria (PNH). Each episode was preceded by urticaria and arthralgia. After developing PNH, haemolysis occurred prior to meningitis. Flow cytometry revealed deficiency of the glycophosphatidylinositol (GPI)-anchored complement regulatory proteins, CD59 and CD55, and he was diagnosed with PNH. All the symptoms disappeared on administering eculizumab, an anti-C5 antibody. We did not detect mutation in PIGA, which is regarded as the cause of PNH. However, we detected a germ-line mutation and a somatic microdeletion in chromosome 20q including PIGT; PIGT is essential for transferring GPI anchor to the precursors of CD59 and CD55, which play important roles in complement regulation. Loss of these proteins leads to complement overactivation, causing inflammatory symptoms, including recurrent meningitis. PIGT mutations should be considered a novel pathogenesis of recurrent meningitis of unknown aetiology. BMJ Publishing Group 2018-09-27 /pmc/articles/PMC6169622/ /pubmed/30262533 http://dx.doi.org/10.1136/bcr-2018-225910 Text en © BMJ Publishing Group Limited 2018. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Findings That Shed New Light on the Possible Pathogenesis of a Disease or an Adverse Effect Kawamoto, Michi Murakami, Yoshiko Kinoshita, Taroh Kohara, Nobuo Recurrent aseptic meningitis with PIGT mutations: a novel pathogenesis of recurrent meningitis successfully treated by eculizumab |
title | Recurrent aseptic meningitis with PIGT mutations: a novel pathogenesis of recurrent meningitis successfully treated by eculizumab |
title_full | Recurrent aseptic meningitis with PIGT mutations: a novel pathogenesis of recurrent meningitis successfully treated by eculizumab |
title_fullStr | Recurrent aseptic meningitis with PIGT mutations: a novel pathogenesis of recurrent meningitis successfully treated by eculizumab |
title_full_unstemmed | Recurrent aseptic meningitis with PIGT mutations: a novel pathogenesis of recurrent meningitis successfully treated by eculizumab |
title_short | Recurrent aseptic meningitis with PIGT mutations: a novel pathogenesis of recurrent meningitis successfully treated by eculizumab |
title_sort | recurrent aseptic meningitis with pigt mutations: a novel pathogenesis of recurrent meningitis successfully treated by eculizumab |
topic | Findings That Shed New Light on the Possible Pathogenesis of a Disease or an Adverse Effect |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169622/ https://www.ncbi.nlm.nih.gov/pubmed/30262533 http://dx.doi.org/10.1136/bcr-2018-225910 |
work_keys_str_mv | AT kawamotomichi recurrentasepticmeningitiswithpigtmutationsanovelpathogenesisofrecurrentmeningitissuccessfullytreatedbyeculizumab AT murakamiyoshiko recurrentasepticmeningitiswithpigtmutationsanovelpathogenesisofrecurrentmeningitissuccessfullytreatedbyeculizumab AT kinoshitataroh recurrentasepticmeningitiswithpigtmutationsanovelpathogenesisofrecurrentmeningitissuccessfullytreatedbyeculizumab AT koharanobuo recurrentasepticmeningitiswithpigtmutationsanovelpathogenesisofrecurrentmeningitissuccessfullytreatedbyeculizumab |